FASN and prostate neoplasm: To assess epithelial FASN protein expression across a racially diverse JHU primary tumor cohort, we digitally quantified a validated FASN IHC assay (Supplementary Fig. S1) in benign glands and primary prostate tumor epithelial cells (Supplementary Fig. S2).